FDA Gives Pharma a Boost to Develop OTC Opioid Overdose Antidote

Bookmark
(Bloomberg) -- The Food and Drug Administration is trying to make it easier for drug companies to make nonprescription versions of opioid overdose antidote naloxone.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.